Cargando…

Editorial: Immune determinants of COVID-19 protection and disease: A focus on asymptomatic COVID and long COVID

Detalles Bibliográficos
Autores principales:	Polyak, Maria J., Abrahamyan, Levon, Bego, Mariana G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086613/ https://www.ncbi.nlm.nih.gov/pubmed/37056777 http://dx.doi.org/10.3389/fimmu.2023.1185693

Ejemplares similares

Editorial: Dysregulation of immunity predisposing to severe COVID-19 infection
por: Halwani, Rabih, et al.
Publicado: (2022)

Editorial: Definition of the immune parameters related to COVID-19 severity
por: Tincati, Camilla, et al.
Publicado: (2023)

COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics
por: Spihlman, Allison P., et al.
Publicado: (2020)

Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
por: Sen, Kaushik, et al.
Publicado: (2021)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
por: Nunès, Jacques A., et al.
Publicado: (2023)

Editorial: Complement and COVID-19 Disease
por: Prohászka, Zoltán, et al.
Publicado: (2022)

Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19
por: Shi, Lei, et al.
Publicado: (2021)

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients
por: Wang, Xiaorui, et al.
Publicado: (2022)

Editorial: Interactions between COVID-19 and malaria
por: Yanow, Stephanie K., et al.
Publicado: (2023)

Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids
por: Ayesh, Hazem, et al.
Publicado: (2021)

T-Cell Repertoire Characteristics of Asymptomatic and Re-Detectable Positive COVID-19 Patients
por: Li, Yizhe, et al.
Publicado: (2022)

An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19
por: Soleimanian, Saeede, et al.
Publicado: (2022)

Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
por: Siemińska, Izabela, et al.
Publicado: (2021)

Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women
por: Rehman, Suriya, et al.
Publicado: (2021)

Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
por: Kzhyshkowska, Julia, et al.
Publicado: (2022)

Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients
por: Zhang, Jiaqi, et al.
Publicado: (2021)

The relationship between chronic immune response and neurodegenerative damage in long COVID-19
por: Elizalde-Díaz, José Pedro, et al.
Publicado: (2022)

Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
por: Zappasodi, Roberta, et al.
Publicado: (2022)

Editorial: The immunological role of platelet activation in the pathophysiology of COVID-19
por: Rossouw, Theresa Marie, et al.
Publicado: (2023)

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies
por: Frederiksen, Lea Skak Filtenborg, et al.
Publicado: (2020)

New Biomarkers of Innate and Adaptive Immunity in Infectious Diseases
por: Morzunov, Sergey, et al.
Publicado: (2017)

Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors
por: Rzymski, Piotr
Publicado: (2023)

Immune Correlates of COVID-19 Control
por: Poonia, Bhawna, et al.
Publicado: (2020)

The Immune Response and Immunopathology of COVID-19
por: Mortaz, Esmaeil, et al.
Publicado: (2020)

Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID
por: Ancona, Giuseppe, et al.
Publicado: (2023)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
por: Andersson, Patrik, et al.
Publicado: (2019)

Editorial: The Role of Reactive Oxygen Species in Protective Immunity
por: Martinvalet, Denis, et al.
Publicado: (2022)

Editorial: Long Non-coding RNAs and Immunity
por: Kwon, Grace J., et al.
Publicado: (2019)

Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19
por: Gong, Wenping, et al.
Publicado: (2023)

Editorial: Beneficial and pathological roles of myeloid cells during COVID-19
por: Sharma, Lokesh, et al.
Publicado: (2023)

Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19
por: Jaiswal, Sarita Rani, et al.
Publicado: (2022)

The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences
por: Filgueira, Tayrine Ordonio, et al.
Publicado: (2021)

The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19
por: Jevtic, Stefan D., et al.
Publicado: (2022)

Editorial: Host immune response and protective immune responses during filarial infections
por: Ritter, Manuel, et al.
Publicado: (2022)

Cellular Immune Response to COVID-19 and Potential Immune Modulators
por: Zhou, Xi, et al.
Publicado: (2021)

Covid-19: Perspectives on Innate Immune Evasion
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Breastfeeding and COVID-19: From Nutrition to Immunity
por: Vassilopoulou, Emilia, et al.
Publicado: (2021)

HLA, Immune Response, and Susceptibility to COVID-19
por: Tavasolian, Fataneh, et al.
Publicado: (2021)

Immune Response to COVID-19 During Pregnancy
por: Chen, Ge, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kqml42p5g5ik4o5uln9g4ovdtq